UBE2B is implicated in myofibrillar protein loss in catabolic C2C12 myotubes. 2016

Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
INRA, UMR 1019, UNH, CRNH Auvergne Saint Genès Champanelle F-63122 France; Clermont Université, Université d'Auvergne, Unité de Nutrition Humaine BP 10448 Clermont-Ferrand F-63000 France.

Skeletal muscle protein loss is an adaptive response to various patho-physiological situations, and the ubiquitin proteasome system (UPS) is responsible for the degradation of the bulk of muscle proteins. The role of E2 ubiquitin-conjugating enzymes is still poorly understood in skeletal muscle. We screened for E2s expression levels in C2C12 myotubes submitted to the catabolic glucocorticoid dexamethasone (Dex). One micromolar Dex induced an accumulation of proteasome substrates (polyUb conjugates) and an overexpression of the muscle-specific E3 ligase MuRF1 and of six E2 enzymes, UBE2A, UBE2B, UBE2D1, UBE2D2, UBE2G1, and UBE2J1. However, only MuRF1 and UBE2B were sensitive to mild catabolic conditions (0.16 μM Dex). UBE2B knockdown induced a sharp decrease of total (-18%) and K48 (-28%) Ub conjugates, that is, proteasome substrates, indicating an important role of UBE2B in the overall protein breakdown in catabolic myotubes. Interestingly, these results indicate an important role of UBE2B on muscle protein homeostasis during catabolic conditions.

UI MeSH Term Description Entries

Related Publications

Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
April 2022, Biochimie,
Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
July 2021, Cells,
Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
January 2010, Experimental cell research,
Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
July 2007, Bioscience, biotechnology, and biochemistry,
Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
February 2001, The Journal of biological chemistry,
Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
November 2006, American journal of physiology. Cell physiology,
Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
June 2020, Biology,
Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
December 2018, Marine drugs,
Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
June 2014, Molecular and cellular biochemistry,
Cécile Polge, and Roza Leulmi, and Marianne Jarzaguet, and Agnes Claustre, and Lydie Combaret, and Daniel Béchet, and Anne-Elisabeth Heng, and Didier Attaix, and Daniel Taillandier
January 2005, Cell biochemistry and function,
Copied contents to your clipboard!